SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5n5n'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1IA0_B_TXLB502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 LEU B 217
ASP B 226
PHE B 272
ARG B 320
PRO B 360
 None
 1.01A 1ia0B-5n5nB:
45.7		 1ia0B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1IA0_B_TXLB502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 LEU B 217
PHE B 272
THR B 276
ARG B 320
PRO B 360
 None
 0.97A 1ia0B-5n5nB:
45.7		 1ia0B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1IA0_B_TXLB502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 LEU B 217
THR B 276
ARG B 320
PRO B 360
GLY B 370
 None
 0.81A 1ia0B-5n5nB:
45.7		 1ia0B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1IA0_B_TXLB502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
HIS B 229
SER B 236
ARG B 320
PRO B 360
GLY B 370
 None
 1.14A 1ia0B-5n5nB:
45.7		 1ia0B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1IA0_B_TXLB502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
LEU B 217
HIS B 229
ARG B 320
PRO B 360
GLY B 370
 None
 1.00A 1ia0B-5n5nB:
45.7		 1ia0B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1IA0_B_TXLB502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
LEU B 217
HIS B 229
PHE B 272
ARG B 320
PRO B 360
 None
 1.01A 1ia0B-5n5nB:
45.7		 1ia0B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1JFF_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
HIS B 229
SER B 236
THR B 276
 None
 1.17A 1jffB-5n5nB:
54.6		 1jffB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1JFF_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
HIS B 229
THR B 276
 None
 1.08A 1jffB-5n5nB:
54.6		 1jffB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1JFF_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
GLU B  27
HIS B 229
SER B 236
PHE B 272
THR B 276
PRO B 360
GLY B 370
 None
 0.99A 1jffB-5n5nB:
54.6		 1jffB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1JFF_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
GLU B  27
LEU B 217
HIS B 229
PHE B 272
THR B 276
PRO B 360
GLY B 370
 None
 0.89A 1jffB-5n5nB:
54.6		 1jffB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1JFF_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
LEU B 217
HIS B 229
PHE B 272
LEU B 275
THR B 276
PRO B 360
GLY B 370
 None
 0.88A 1jffB-5n5nB:
54.6		 1jffB-5n5nB:
97.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1P91_A_SAMA1401_0
(RIBOSOMAL RNA LARGE
SUBUNIT
METHYLTRANSFERASE A)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 11 LEU B 141
GLY B 148
GLY B 146
ILE B 154
LEU B 428
 None
None
G2P  B 501 (-3.5A)
None
None
 1.01A 1p91A-5n5nB:
2.3		 1p91A-5n5nB:
21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RJD_A_SAMA801_0
(CARBOXY METHYL
TRANSFERASE FOR
PROTEIN PHOSPHATASE
2A CATALYTIC SUBUNIT)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 ALA B  99
GLY B 150
GLY B 148
SER B 190
LEU B 137
 G2P  B 501 ( 4.6A)
None
None
None
None
 1.01A 1rjdA-5n5nB:
3.5		 1rjdA-5n5nB:
22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RJD_B_SAMB802_0
(CARBOXY METHYL
TRANSFERASE FOR
PROTEIN PHOSPHATASE
2A CATALYTIC SUBUNIT)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 ALA B  99
GLY B 150
GLY B 148
SER B 190
LEU B 137
 G2P  B 501 ( 4.6A)
None
None
None
None
 1.02A 1rjdB-5n5nB:
undetectable		 1rjdB-5n5nB:
22.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RJD_C_SAMC803_0
(CARBOXY METHYL
TRANSFERASE FOR
PROTEIN PHOSPHATASE
2A CATALYTIC SUBUNIT)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 ALA B  99
GLY B 150
GLY B 148
SER B 190
LEU B 137
 G2P  B 501 ( 4.6A)
None
None
None
None
 0.97A 1rjdC-5n5nB:
undetectable		 1rjdC-5n5nB:
22.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 ALA B 250
LEU B 255
ASN B 258
MET B 259
ALA B 316
 None
 1.11A 1sa1A-5n5nB:
50.6
1sa1B-5n5nB:
53.1		 1sa1A-5n5nB:
40.88
1sa1B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SA1_B_PODB700_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 CYH B 241
LEU B 242
LEU B 252
VAL B 318
ALA B 354
 None
 1.02A 1sa1A-5n5nB:
50.6
1sa1B-5n5nB:
53.1		 1sa1A-5n5nB:
40.88
1sa1B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SA1_D_PODD701_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 ALA B 250
LEU B 255
ASN B 258
MET B 259
ALA B 316
 None
 1.12A 1sa1C-5n5nB:
50.5
1sa1D-5n5nB:
52.9		 1sa1C-5n5nB:
40.88
1sa1D-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SA1_D_PODD701_1
(TUBULIN ALPHA CHAIN
TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 CYH B 241
LEU B 242
LEU B 252
VAL B 318
ALA B 354
 None
 1.01A 1sa1C-5n5nB:
50.5
1sa1D-5n5nB:
52.9		 1sa1C-5n5nB:
40.88
1sa1D-5n5nB:
97.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1SS4_A_ACTA411_0
(GLYOXALASE FAMILY
PROTEIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		4 / 5 VAL B 238
THR B 239
GLN B 136
ILE B 165
 None
 1.07A 1ss4A-5n5nB:
undetectable		 1ss4A-5n5nB:
17.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1T7I_A_017A200_1
(POL POLYPROTEIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 10 GLY B  10
ALA B   9
GLY B  17
ILE B  16
THR B 168
 G2P  B 501 ( 3.7A)
None
None
None
None
 1.01A 1t7iA-5n5nB:
undetectable		 1t7iA-5n5nB:
12.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1TUB_B_TXLB501_1
(TUBULIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 LEU B 217
ASP B 226
PHE B 272
ARG B 320
PRO B 360
 None
 1.02A 1tubB-5n5nB:
45.7		 1tubB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1TUB_B_TXLB501_1
(TUBULIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 LEU B 217
PHE B 272
THR B 276
ARG B 320
PRO B 360
 None
 0.97A 1tubB-5n5nB:
45.7		 1tubB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1TUB_B_TXLB501_1
(TUBULIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 LEU B 217
THR B 276
ARG B 320
PRO B 360
GLY B 370
 None
 0.81A 1tubB-5n5nB:
45.7		 1tubB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1TUB_B_TXLB501_1
(TUBULIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
HIS B 229
SER B 236
ARG B 320
PRO B 360
GLY B 370
 None
 1.14A 1tubB-5n5nB:
45.7		 1tubB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1TUB_B_TXLB501_1
(TUBULIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
LEU B 217
HIS B 229
ARG B 320
PRO B 360
GLY B 370
 None
 1.00A 1tubB-5n5nB:
45.7		 1tubB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1TUB_B_TXLB501_1
(TUBULIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
LEU B 217
HIS B 229
PHE B 272
ARG B 320
PRO B 360
 None
 1.01A 1tubB-5n5nB:
45.7		 1tubB-5n5nB:
97.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XF1_A_ACTA1107_0
(C5A PEPTIDASE)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		4 / 5 LEU B 153
GLY B 150
HIS B 139
ILE B   7
 None
 0.86A 1xf1A-5n5nB:
undetectable		 1xf1A-5n5nB:
17.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XF1_B_ACTB1108_0
(C5A PEPTIDASE)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		4 / 6 LEU B 153
GLY B 150
HIS B 139
ILE B   7
 None
 0.85A 1xf1B-5n5nB:
2.6		 1xf1B-5n5nB:
17.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A1O_A_CAMA1422_0
(CYTOCHROME P450-CAM)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		4 / 8 PHE B 169
THR B 239
LEU B 252
GLY B 134
 None
 0.92A 2a1oA-5n5nB:
undetectable		 2a1oA-5n5nB:
21.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HDN_F_TACF3888_1
(ELONGATION FACTOR
EF-TU)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		4 / 7 THR B 151
SER B 170
VAL B 172
LEU B 428
 None
 0.91A 2hdnE-5n5nB:
undetectable
2hdnF-5n5nB:
2.4
2hdnH-5n5nB:
2.5		 2hdnE-5n5nB:
6.10
2hdnF-5n5nB:
23.21
2hdnH-5n5nB:
23.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2HDN_H_TACH4888_1
(ELONGATION FACTOR
EF-TU)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		4 / 7 SER B 170
VAL B 172
LEU B 428
THR B 151
 None
 0.93A 2hdnF-5n5nB:
2.4
2hdnG-5n5nB:
undetectable
2hdnH-5n5nB:
2.5		 2hdnF-5n5nB:
23.21
2hdnG-5n5nB:
6.10
2hdnH-5n5nB:
23.21
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HXF_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
HIS B 229
SER B 236
THR B 276
 None
 1.17A 2hxfB-5n5nB:
54.6		 2hxfB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HXF_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
HIS B 229
THR B 276
 None
 1.08A 2hxfB-5n5nB:
54.6		 2hxfB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HXF_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
GLU B  27
HIS B 229
SER B 236
PHE B 272
THR B 276
PRO B 360
GLY B 370
 None
 0.98A 2hxfB-5n5nB:
54.6		 2hxfB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HXF_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
GLU B  27
LEU B 217
HIS B 229
PHE B 272
THR B 276
PRO B 360
GLY B 370
 None
 0.89A 2hxfB-5n5nB:
54.6		 2hxfB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HXF_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
LEU B 217
HIS B 229
PHE B 272
LEU B 275
THR B 276
PRO B 360
GLY B 370
 None
 0.88A 2hxfB-5n5nB:
54.6		 2hxfB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HXH_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
HIS B 229
SER B 236
THR B 276
 None
 1.17A 2hxhB-5n5nB:
54.6		 2hxhB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HXH_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
HIS B 229
THR B 276
 None
 1.08A 2hxhB-5n5nB:
54.6		 2hxhB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HXH_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
GLU B  27
HIS B 229
SER B 236
PHE B 272
THR B 276
PRO B 360
GLY B 370
 None
 0.98A 2hxhB-5n5nB:
54.6		 2hxhB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HXH_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
GLU B  27
LEU B 217
HIS B 229
PHE B 272
THR B 276
PRO B 360
GLY B 370
 None
 0.89A 2hxhB-5n5nB:
54.6		 2hxhB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HXH_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
LEU B 217
HIS B 229
PHE B 272
LEU B 275
THR B 276
PRO B 360
GLY B 370
 None
 0.88A 2hxhB-5n5nB:
54.6		 2hxhB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2P4N_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
HIS B 229
SER B 236
THR B 276
 None
 1.17A 2p4nB-5n5nB:
38.9		 2p4nB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2P4N_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
HIS B 229
THR B 276
 None
 1.07A 2p4nB-5n5nB:
38.9		 2p4nB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2P4N_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
GLU B  27
HIS B 229
SER B 236
PHE B 272
THR B 276
PRO B 360
GLY B 370
 None
 0.99A 2p4nB-5n5nB:
38.9		 2p4nB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2P4N_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
GLU B  27
LEU B 217
HIS B 229
PHE B 272
THR B 276
PRO B 360
GLY B 370
 None
 0.89A 2p4nB-5n5nB:
38.9		 2p4nB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2P4N_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
LEU B 217
HIS B 229
PHE B 272
LEU B 275
THR B 276
PRO B 360
GLY B 370
 None
 0.88A 2p4nB-5n5nB:
38.9		 2p4nB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2WBE_B_TA1B1439_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
HIS B 229
SER B 236
THR B 276
 None
 1.17A 2wbeB-5n5nB:
54.6		 2wbeB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2WBE_B_TA1B1439_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
HIS B 229
THR B 276
 None
 1.08A 2wbeB-5n5nB:
54.6		 2wbeB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2WBE_B_TA1B1439_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
GLU B  27
HIS B 229
SER B 236
PHE B 272
THR B 276
PRO B 360
GLY B 370
 None
 0.98A 2wbeB-5n5nB:
54.6		 2wbeB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2WBE_B_TA1B1439_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
GLU B  27
LEU B 217
HIS B 229
PHE B 272
THR B 276
PRO B 360
GLY B 370
 None
 0.89A 2wbeB-5n5nB:
54.6		 2wbeB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2WBE_B_TA1B1439_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
LEU B 217
HIS B 229
PHE B 272
LEU B 275
THR B 276
PRO B 360
GLY B 370
 None
 0.88A 2wbeB-5n5nB:
54.6		 2wbeB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DCO_B_TA1B601_1
(BOVINE BETA TUBULIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
HIS B 229
SER B 236
THR B 276
 None
 1.17A 3dcoB-5n5nB:
38.9		 3dcoB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DCO_B_TA1B601_1
(BOVINE BETA TUBULIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
HIS B 229
THR B 276
 None
 1.08A 3dcoB-5n5nB:
38.9		 3dcoB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DCO_B_TA1B601_1
(BOVINE BETA TUBULIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
GLU B  27
HIS B 229
SER B 236
PHE B 272
THR B 276
PRO B 360
GLY B 370
 None
 0.98A 3dcoB-5n5nB:
38.9		 3dcoB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DCO_B_TA1B601_1
(BOVINE BETA TUBULIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
GLU B  27
LEU B 217
HIS B 229
PHE B 272
THR B 276
PRO B 360
GLY B 370
 None
 0.89A 3dcoB-5n5nB:
38.9		 3dcoB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3DCO_B_TA1B601_1
(BOVINE BETA TUBULIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
LEU B 217
HIS B 229
PHE B 272
LEU B 275
THR B 276
PRO B 360
GLY B 370
 None
 0.88A 3dcoB-5n5nB:
38.9		 3dcoB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EDL_B_TA1B601_1
(BETA TUBULIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
HIS B 229
SER B 236
THR B 276
 None
 1.19A 3edlB-5n5nB:
54.6		 3edlB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EDL_B_TA1B601_1
(BETA TUBULIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
HIS B 229
THR B 276
 None
 1.09A 3edlB-5n5nB:
54.6		 3edlB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EDL_B_TA1B601_1
(BETA TUBULIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
GLU B  27
HIS B 229
SER B 236
PHE B 272
THR B 276
PRO B 360
GLY B 370
 None
 0.97A 3edlB-5n5nB:
54.6		 3edlB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EDL_B_TA1B601_1
(BETA TUBULIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
GLU B  27
LEU B 217
HIS B 229
PHE B 272
THR B 276
PRO B 360
GLY B 370
 None
 0.90A 3edlB-5n5nB:
54.6		 3edlB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EDL_B_TA1B601_1
(BETA TUBULIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
LEU B 217
HIS B 229
PHE B 272
LEU B 275
THR B 276
PRO B 360
GLY B 370
 None
 0.88A 3edlB-5n5nB:
54.6		 3edlB-5n5nB:
97.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FL9_F_TOPF200_1
(DIHYDROFOLATE
REDUCTASE (DHFR))		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 10 ALA B 421
ASN B 186
LEU B 189
LEU B 405
PHE B 399
 None
 1.12A 3fl9F-5n5nB:
undetectable		 3fl9F-5n5nB:
15.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3IZ0_B_TA1B820_1
(BETA TUBULIN, CHAIN
B FROM PDB 1JFF)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
HIS B 229
SER B 236
THR B 276
 None
 1.16A 3iz0B-5n5nB:
38.9		 3iz0B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3IZ0_B_TA1B820_1
(BETA TUBULIN, CHAIN
B FROM PDB 1JFF)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
HIS B 229
THR B 276
 None
 1.04A 3iz0B-5n5nB:
38.9		 3iz0B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3IZ0_B_TA1B820_1
(BETA TUBULIN, CHAIN
B FROM PDB 1JFF)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
GLU B  27
HIS B 229
SER B 236
PHE B 272
THR B 276
PRO B 360
GLY B 370
 None
 0.96A 3iz0B-5n5nB:
38.9		 3iz0B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3IZ0_B_TA1B820_1
(BETA TUBULIN, CHAIN
B FROM PDB 1JFF)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
GLU B  27
LEU B 217
HIS B 229
PHE B 272
THR B 276
PRO B 360
GLY B 370
 None
 0.87A 3iz0B-5n5nB:
38.9		 3iz0B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3IZ0_B_TA1B820_1
(BETA TUBULIN, CHAIN
B FROM PDB 1JFF)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
LEU B 217
HIS B 229
PHE B 272
LEU B 275
THR B 276
PRO B 360
GLY B 370
 None
 0.85A 3iz0B-5n5nB:
38.9		 3iz0B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
HIS B 229
LEU B 230
PHE B 272
THR B 276
GLN B 281
 None
 1.01A 3j6gB-5n5nB:
57.1		 3j6gB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
HIS B 229
SER B 236
PHE B 272
THR B 276
GLN B 281
 None
 1.03A 3j6gB-5n5nB:
57.1		 3j6gB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
LEU B 230
PHE B 272
THR B 276
GLN B 281
LEU B 371
 None
 1.07A 3j6gB-5n5nB:
57.1		 3j6gB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
SER B 236
PHE B 272
THR B 276
GLN B 281
LEU B 371
 None
 1.10A 3j6gB-5n5nB:
57.1		 3j6gB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_D_TA1D502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
HIS B 229
LEU B 230
PHE B 272
THR B 276
GLN B 281
 None
 1.00A 3j6gD-5n5nB:
57.1		 3j6gD-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_D_TA1D502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
HIS B 229
SER B 236
PHE B 272
THR B 276
GLN B 281
 None
 1.03A 3j6gD-5n5nB:
57.1		 3j6gD-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_D_TA1D502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
LEU B 230
PHE B 272
THR B 276
GLN B 281
LEU B 371
 None
 1.07A 3j6gD-5n5nB:
57.1		 3j6gD-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_D_TA1D502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
SER B 236
PHE B 272
THR B 276
GLN B 281
LEU B 371
 None
 1.10A 3j6gD-5n5nB:
57.1		 3j6gD-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_F_TA1F502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
HIS B 229
LEU B 230
PHE B 272
THR B 276
GLN B 281
 None
 1.01A 3j6gF-5n5nB:
57.1		 3j6gF-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_F_TA1F502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
HIS B 229
SER B 236
PHE B 272
THR B 276
GLN B 281
 None
 1.03A 3j6gF-5n5nB:
57.1		 3j6gF-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_F_TA1F502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
LEU B 230
PHE B 272
THR B 276
GLN B 281
LEU B 371
 None
 1.07A 3j6gF-5n5nB:
57.1		 3j6gF-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_F_TA1F502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
SER B 236
PHE B 272
THR B 276
GLN B 281
LEU B 371
 None
 1.10A 3j6gF-5n5nB:
57.1		 3j6gF-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_H_TA1H502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
HIS B 229
LEU B 230
PHE B 272
THR B 276
GLN B 281
 None
 1.01A 3j6gH-5n5nB:
57.1		 3j6gH-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_H_TA1H502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
HIS B 229
SER B 236
PHE B 272
THR B 276
GLN B 281
 None
 1.03A 3j6gH-5n5nB:
57.1		 3j6gH-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_H_TA1H502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
LEU B 230
PHE B 272
THR B 276
GLN B 281
LEU B 371
 None
 1.07A 3j6gH-5n5nB:
57.1		 3j6gH-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_H_TA1H502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
SER B 236
PHE B 272
THR B 276
GLN B 281
LEU B 371
 None
 1.10A 3j6gH-5n5nB:
57.1		 3j6gH-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_J_TA1J502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
HIS B 229
LEU B 230
PHE B 272
THR B 276
GLN B 281
 None
 1.01A 3j6gJ-5n5nB:
57.1		 3j6gJ-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_J_TA1J502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
HIS B 229
SER B 236
PHE B 272
THR B 276
GLN B 281
 None
 1.03A 3j6gJ-5n5nB:
57.1		 3j6gJ-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_J_TA1J502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
LEU B 230
PHE B 272
THR B 276
GLN B 281
LEU B 371
 None
 1.07A 3j6gJ-5n5nB:
57.1		 3j6gJ-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_J_TA1J502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
SER B 236
PHE B 272
THR B 276
GLN B 281
LEU B 371
 None
 1.10A 3j6gJ-5n5nB:
57.1		 3j6gJ-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_L_TA1L502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
HIS B 229
LEU B 230
PHE B 272
THR B 276
GLN B 281
 None
 1.00A 3j6gL-5n5nB:
57.0		 3j6gL-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_L_TA1L502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
HIS B 229
SER B 236
PHE B 272
THR B 276
GLN B 281
 None
 1.03A 3j6gL-5n5nB:
57.0		 3j6gL-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_L_TA1L502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
LEU B 230
PHE B 272
THR B 276
GLN B 281
LEU B 371
 None
 1.07A 3j6gL-5n5nB:
57.0		 3j6gL-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_L_TA1L502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
SER B 236
PHE B 272
THR B 276
GLN B 281
LEU B 371
 None
 1.10A 3j6gL-5n5nB:
57.0		 3j6gL-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_N_TA1N502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
HIS B 229
LEU B 230
PHE B 272
THR B 276
GLN B 281
 None
 1.01A 3j6gN-5n5nB:
57.1		 3j6gN-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_N_TA1N502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
HIS B 229
SER B 236
PHE B 272
THR B 276
GLN B 281
 None
 1.03A 3j6gN-5n5nB:
57.1		 3j6gN-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_N_TA1N502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
LEU B 230
PHE B 272
THR B 276
GLN B 281
LEU B 371
 None
 1.07A 3j6gN-5n5nB:
57.1		 3j6gN-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_N_TA1N502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
SER B 236
PHE B 272
THR B 276
GLN B 281
LEU B 371
 None
 1.10A 3j6gN-5n5nB:
57.1		 3j6gN-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_P_TA1P502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
HIS B 229
LEU B 230
PHE B 272
THR B 276
GLN B 281
 None
 1.01A 3j6gP-5n5nB:
57.1		 3j6gP-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_P_TA1P502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
HIS B 229
SER B 236
PHE B 272
THR B 276
GLN B 281
 None
 1.03A 3j6gP-5n5nB:
57.1		 3j6gP-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_P_TA1P502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
LEU B 230
PHE B 272
THR B 276
GLN B 281
LEU B 371
 None
 1.07A 3j6gP-5n5nB:
57.1		 3j6gP-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_P_TA1P502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
SER B 236
PHE B 272
THR B 276
GLN B 281
LEU B 371
 None
 1.10A 3j6gP-5n5nB:
57.1		 3j6gP-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_R_TA1R502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
HIS B 229
LEU B 230
PHE B 272
THR B 276
GLN B 281
 None
 1.01A 3j6gR-5n5nB:
57.1		 3j6gR-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_R_TA1R502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
HIS B 229
SER B 236
PHE B 272
THR B 276
GLN B 281
 None
 1.03A 3j6gR-5n5nB:
57.1		 3j6gR-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_R_TA1R502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
LEU B 230
PHE B 272
THR B 276
GLN B 281
LEU B 371
 None
 1.07A 3j6gR-5n5nB:
57.1		 3j6gR-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6G_R_TA1R502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
SER B 236
PHE B 272
THR B 276
GLN B 281
LEU B 371
 None
 1.10A 3j6gR-5n5nB:
57.1		 3j6gR-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6P_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 GLU B  27
LEU B 217
PHE B 272
THR B 276
PRO B 360
GLY B 370
LEU B 371
 None
 1.22A 3j6pB-5n5nB:
54.0		 3j6pB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6P_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 GLU B  27
SER B 236
PHE B 272
THR B 276
PRO B 360
GLY B 370
LEU B 371
 None
 1.28A 3j6pB-5n5nB:
54.0		 3j6pB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6P_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 VAL B  23
ASP B  26
HIS B 229
SER B 236
THR B 276
 None
 1.23A 3j6pB-5n5nB:
54.0		 3j6pB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6P_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 VAL B  23
ASP B  26
LEU B 217
HIS B 229
THR B 276
 None
 1.09A 3j6pB-5n5nB:
54.0		 3j6pB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6P_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
GLU B  27
HIS B 229
SER B 236
PHE B 272
THR B 276
PRO B 360
GLY B 370
 None
 1.02A 3j6pB-5n5nB:
54.0		 3j6pB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3J6P_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
GLU B  27
LEU B 217
HIS B 229
PHE B 272
THR B 276
PRO B 360
GLY B 370
 None
 0.92A 3j6pB-5n5nB:
54.0		 3j6pB-5n5nB:
97.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3S3O_A_DLUA399_1
(PFV INTEGRASE)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		4 / 7 ASP B  69
PRO B  72
GLN B  96
GLU B  71
 MG  B 502 ( 4.0A)
None
None
None
 1.16A 3s3oA-5n5nB:
undetectable		 3s3oA-5n5nB:
21.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3UGR_A_IMNA2001_2
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		4 / 7 TYR B  52
GLU B 200
GLN B 133
PRO B 270
 None
 1.16A 3ugrA-5n5nB:
undetectable		 3ugrA-5n5nB:
22.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UT5_B_LOCB502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 ALA B 250
LYS B 254
ASN B 258
MET B 259
THR B 314
ILE B 378
 None
 0.84A 3ut5B-5n5nB:
54.4		 3ut5B-5n5nB:
96.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UT5_B_LOCB502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 LEU B 255
ASN B 258
MET B 259
THR B 314
ILE B 378
 None
 0.92A 3ut5B-5n5nB:
54.4		 3ut5B-5n5nB:
96.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UT5_B_LOCB502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 LEU B 255
MET B 259
THR B 314
ALA B 316
ILE B 378
 None
 1.02A 3ut5B-5n5nB:
54.4		 3ut5B-5n5nB:
96.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UT5_D_LOCD502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 ALA B 250
LYS B 254
ASN B 258
MET B 259
ILE B 378
 None
 0.80A 3ut5D-5n5nB:
53.8		 3ut5D-5n5nB:
96.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ZMD_A_SALA201_1
(PUTATIVE
TRANSCRIPTIONAL
REGULATOR)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		4 / 8 TRP B 103
MET B 413
TYR B 408
GLU B 411
 None
 1.24A 3zmdA-5n5nB:
undetectable
3zmdB-5n5nB:
undetectable		 3zmdA-5n5nB:
18.27
3zmdB-5n5nB:
18.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ZOA_A_ACRA1587_2
(TREHALOSE
SYNTHASE/AMYLASE
TRES)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		3 / 3 ARG B 243
PHE B 244
PRO B 245
 None
 0.89A 3zoaB-5n5nB:
2.0		 3zoaB-5n5nB:
21.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NJT_B_017B101_2
(PROTEASE)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 10 GLY B  10
ALA B   9
GLY B  17
ILE B  16
THR B 168
 G2P  B 501 ( 3.7A)
None
None
None
None
 0.98A 4njtB-5n5nB:
undetectable		 4njtB-5n5nB:
14.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4O2B_B_LOCB503_2
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 LEU B 255
ASN B 258
MET B 259
THR B 314
ILE B 378
 None
 0.91A 4o2bB-5n5nB:
55.9		 4o2bB-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4O2B_B_LOCB503_2
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 LEU B 255
MET B 259
THR B 314
ALA B 316
ILE B 378
 None
 1.02A 4o2bB-5n5nB:
55.9		 4o2bB-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4X1I_B_LOCB502_2
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 ALA B 250
LYS B 254
ASN B 258
MET B 259
THR B 314
 None
 0.67A 4x1iB-5n5nB:
54.3		 4x1iB-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4X1I_B_LOCB502_2
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 MET B 259
THR B 314
ALA B 316
VAL B 318
ALA B 354
 None
 0.78A 4x1iB-5n5nB:
54.3		 4x1iB-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4X1I_D_LOCD502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 LEU B 255
ASN B 258
MET B 259
THR B 314
ILE B 378
 None
 0.80A 4x1iD-5n5nB:
53.4		 4x1iD-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4X1I_D_LOCD502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 LEU B 255
MET B 259
THR B 314
ALA B 316
ILE B 378
 None
 0.93A 4x1iD-5n5nB:
53.4		 4x1iD-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4X1I_D_LOCD502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 MET B 259
THR B 314
ALA B 316
ALA B 354
ILE B 378
 None
 0.69A 4x1iD-5n5nB:
53.4		 4x1iD-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4X1K_D_LOCD502_2
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 LEU B 252
THR B 314
ALA B 316
VAL B 318
ALA B 354
ILE B 378
 None
 1.00A 4x1kD-5n5nB:
53.4		 4x1kD-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4X1K_D_LOCD502_2
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 LYS B 254
ASN B 258
MET B 259
THR B 314
ILE B 378
 None
 0.80A 4x1kD-5n5nB:
53.4		 4x1kD-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4X1K_D_LOCD502_2
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 MET B 259
THR B 314
ALA B 316
VAL B 318
ALA B 354
ILE B 378
 None
 0.72A 4x1kD-5n5nB:
53.4		 4x1kD-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4X1Y_B_LOCB502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 LEU B 255
ASN B 258
MET B 259
THR B 314
ILE B 378
 None
 0.86A 4x1yB-5n5nB:
54.0		 4x1yB-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4X1Y_B_LOCB502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 LEU B 255
MET B 259
THR B 314
ALA B 316
ILE B 378
 None
 1.02A 4x1yB-5n5nB:
54.0		 4x1yB-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4X1Y_B_LOCB502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 MET B 259
THR B 314
ALA B 316
VAL B 318
ILE B 378
 None
 0.78A 4x1yB-5n5nB:
54.0		 4x1yB-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4X1Y_D_LOCD502_2
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 LEU B 252
THR B 314
ALA B 316
VAL B 318
ALA B 354
ILE B 378
 None
 1.01A 4x1yD-5n5nB:
53.7		 4x1yD-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4X1Y_D_LOCD502_2
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 LEU B 255
ASN B 258
MET B 259
THR B 314
ALA B 316
ILE B 378
 None
 0.93A 4x1yD-5n5nB:
53.7		 4x1yD-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4X1Y_D_LOCD502_2
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 MET B 259
THR B 314
ALA B 316
VAL B 318
ALA B 354
ILE B 378
 None
 0.69A 4x1yD-5n5nB:
53.7		 4x1yD-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4X20_B_LOCB502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 THR B 314
ALA B 316
VAL B 318
ALA B 354
ILE B 378
 None
 0.61A 4x20B-5n5nB:
53.6		 4x20B-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4X20_D_LOCD502_2
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 11 LEU B 252
THR B 314
ALA B 316
VAL B 318
ILE B 378
 None
 1.04A 4x20D-5n5nB:
53.4		 4x20D-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4X20_D_LOCD502_2
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 11 LEU B 255
ASN B 258
MET B 259
THR B 314
ILE B 378
 None
 0.98A 4x20D-5n5nB:
53.4		 4x20D-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4X20_D_LOCD502_2
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 11 LEU B 255
MET B 259
THR B 314
ALA B 316
ILE B 378
 None
 1.06A 4x20D-5n5nB:
53.4		 4x20D-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4X20_D_LOCD502_2
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 11 LYS B 254
ASN B 258
MET B 259
THR B 314
ILE B 378
 None
 0.77A 4x20D-5n5nB:
53.4		 4x20D-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4X20_D_LOCD502_2
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 11 MET B 259
THR B 314
ALA B 316
VAL B 318
ILE B 378
 None
 0.77A 4x20D-5n5nB:
53.4		 4x20D-5n5nB:
97.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ZJL_A_ERYA1101_0
(MULTIDRUG EFFLUX
PUMP SUBUNIT ACRB)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 SER B 178
GLU B 183
GLU B  71
THR B 145
GLY B 144
 None
None
None
G2P  B 501 (-3.2A)
G2P  B 501 ( 4.6A)
 1.24A 4zjlA-5n5nB:
undetectable		 4zjlA-5n5nB:
17.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HJI_A_ADNA401_1
(TRNA
(GUANINE(37)-N1)-MET
HYLTRANSFERASE TRM5A)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 11 LEU B 248
PHE B 319
GLY B 321
ASP B 329
VAL B 328
 None
 1.36A 5hjiA-5n5nB:
undetectable		 5hjiA-5n5nB:
22.27
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNW_B_TA1B902_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
HIS B 229
SER B 236
THR B 276
 None
 1.14A 5hnwB-5n5nB:
54.6		 5hnwB-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNW_B_TA1B902_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
HIS B 229
LEU B 230
THR B 276
 None
 1.24A 5hnwB-5n5nB:
54.6		 5hnwB-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNW_B_TA1B902_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
GLU B  27
HIS B 229
SER B 236
PHE B 272
THR B 276
PRO B 360
 None
 0.92A 5hnwB-5n5nB:
54.6		 5hnwB-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNW_B_TA1B902_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
GLU B  27
LEU B 217
HIS B 229
LEU B 230
PHE B 272
THR B 276
PRO B 360
 None
 1.02A 5hnwB-5n5nB:
54.6		 5hnwB-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNW_B_TA1B902_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
LEU B 217
HIS B 229
LEU B 230
PHE B 272
LEU B 275
THR B 276
PRO B 360
 None
 0.95A 5hnwB-5n5nB:
54.6		 5hnwB-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNX_B_TA1B902_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
HIS B 229
LEU B 230
THR B 276
 None
 1.33A 5hnxB-5n5nB:
54.6		 5hnxB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNX_B_TA1B902_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
HIS B 229
SER B 236
THR B 276
 None
 1.16A 5hnxB-5n5nB:
54.6		 5hnxB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNX_B_TA1B902_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
GLU B  27
HIS B 229
LEU B 230
PHE B 272
THR B 276
PRO B 360
 None
 0.94A 5hnxB-5n5nB:
54.6		 5hnxB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNX_B_TA1B902_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
GLU B  27
HIS B 229
SER B 236
PHE B 272
THR B 276
PRO B 360
 None
 0.85A 5hnxB-5n5nB:
54.6		 5hnxB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNX_B_TA1B902_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
HIS B 229
LEU B 230
PHE B 272
LEU B 275
THR B 276
PRO B 360
 None
 0.92A 5hnxB-5n5nB:
54.6		 5hnxB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNY_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
HIS B 229
SER B 236
THR B 276
 None
 1.12A 5hnyB-5n5nB:
54.6		 5hnyB-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNY_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
HIS B 229
LEU B 230
THR B 276
 None
 1.25A 5hnyB-5n5nB:
54.6		 5hnyB-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNY_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
GLU B  27
HIS B 229
SER B 236
PHE B 272
THR B 276
PRO B 360
 None
 0.93A 5hnyB-5n5nB:
54.6		 5hnyB-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNY_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
GLU B  27
LEU B 217
HIS B 229
LEU B 230
PHE B 272
THR B 276
PRO B 360
 None
 0.98A 5hnyB-5n5nB:
54.6		 5hnyB-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNY_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
LEU B 217
HIS B 229
LEU B 230
PHE B 272
LEU B 275
THR B 276
PRO B 360
 None
 0.93A 5hnyB-5n5nB:
54.6		 5hnyB-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNZ_B_TA1B902_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
HIS B 229
ALA B 233
SER B 236
THR B 276
 None
 1.07A 5hnzB-5n5nB:
54.6		 5hnzB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNZ_B_TA1B902_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
ASP B 226
HIS B 229
ALA B 233
THR B 276
 None
 1.07A 5hnzB-5n5nB:
54.6		 5hnzB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNZ_B_TA1B902_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
GLU B  27
HIS B 229
ALA B 233
SER B 236
PHE B 272
THR B 276
PRO B 360
 None
 0.96A 5hnzB-5n5nB:
54.6		 5hnzB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5HNZ_B_TA1B902_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		9 / 12 VAL B  23
GLU B  27
LEU B 217
ASP B 226
HIS B 229
ALA B 233
PHE B 272
THR B 276
PRO B 360
 None
 0.81A 5hnzB-5n5nB:
54.6		 5hnzB-5n5nB:
97.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I8F_A_ML1A211_1
(PHENOLIC OXIDATIVE
COUPLING PROTEIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		4 / 6 VAL B 375
ALA B 273
GLN B 294
VAL B 295
 None
 1.03A 5i8fA-5n5nB:
undetectable		 5i8fA-5n5nB:
17.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ITZ_B_LOCB502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 LEU B 255
ASN B 258
MET B 259
THR B 314
ILE B 378
 None
 0.88A 5itzB-5n5nB:
53.4		 5itzB-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ITZ_B_LOCB502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 LEU B 255
MET B 259
THR B 314
ALA B 316
ILE B 378
 None
 0.99A 5itzB-5n5nB:
53.4		 5itzB-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M50_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 ASP B  26
GLU B  27
GLN B 281
ARG B 320
PRO B 360
GLY B 370
 None
 1.22A 5m50B-5n5nB:
58.0		 5m50B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M50_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 ASP B  26
GLU B  27
GLN B 281
PRO B 360
GLY B 370
LEU B 371
 None
 1.20A 5m50B-5n5nB:
58.0		 5m50B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M50_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 ASP B  26
GLU B  27
THR B 276
GLN B 281
GLY B 370
LEU B 371
 None
 1.25A 5m50B-5n5nB:
58.0		 5m50B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M50_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 ASP B  26
SER B 236
GLN B 281
PRO B 360
GLY B 370
LEU B 371
 None
 1.13A 5m50B-5n5nB:
58.0		 5m50B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M50_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 ASP B  26
SER B 236
THR B 276
GLN B 281
GLY B 370
LEU B 371
 None
 1.12A 5m50B-5n5nB:
58.0		 5m50B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M50_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
ASP B  26
GLU B  27
GLN B 281
PRO B 360
GLY B 370
 None
 1.14A 5m50B-5n5nB:
58.0		 5m50B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M50_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
HIS B 229
THR B 276
GLN B 281
GLY B 370
 None
 1.12A 5m50B-5n5nB:
58.0		 5m50B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M50_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
ASP B  26
HIS B 229
SER B 236
THR B 276
GLN B 281
GLY B 370
 None
 0.98A 5m50B-5n5nB:
58.0		 5m50B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M50_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
ASP B  26
SER B 236
GLN B 281
PRO B 360
GLY B 370
 None
 1.06A 5m50B-5n5nB:
58.0		 5m50B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M50_E_TA1E502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 ASP B  26
GLU B  27
LEU B 217
GLN B 281
ARG B 320
GLY B 370
 None
 1.19A 5m50E-5n5nB:
undetectable		 5m50E-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M50_E_TA1E502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 ASP B  26
GLU B  27
LEU B 217
THR B 276
GLN B 281
GLY B 370
LEU B 371
 None
 1.22A 5m50E-5n5nB:
undetectable		 5m50E-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M50_E_TA1E502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 ASP B  26
LEU B 217
SER B 236
THR B 276
GLN B 281
GLY B 370
LEU B 371
 None
 1.16A 5m50E-5n5nB:
undetectable		 5m50E-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M50_E_TA1E502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
HIS B 229
GLN B 281
GLY B 370
 None
 1.04A 5m50E-5n5nB:
undetectable		 5m50E-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M50_E_TA1E502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
THR B 276
GLN B 281
GLY B 370
 None
 1.11A 5m50E-5n5nB:
undetectable		 5m50E-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M50_E_TA1E502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
ASP B  26
LEU B 217
HIS B 229
SER B 236
GLN B 281
GLY B 370
 None
 0.98A 5m50E-5n5nB:
undetectable		 5m50E-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M50_E_TA1E502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
ASP B  26
LEU B 217
SER B 236
THR B 276
GLN B 281
GLY B 370
 None
 1.03A 5m50E-5n5nB:
undetectable		 5m50E-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M50_E_TA1E502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
ASP B  26
LEU B 275
HIS B 229
GLN B 281
GLY B 370
 None
 1.35A 5m50E-5n5nB:
undetectable		 5m50E-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M50_E_TA1E502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
ASP B  26
LEU B 275
THR B 276
GLN B 281
GLY B 370
 None
 1.48A 5m50E-5n5nB:
undetectable		 5m50E-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M54_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
ASP B  26
ALA B 233
SER B 236
PHE B 272
THR B 276
GLN B 281
LEU B 371
 None
 1.02A 5m54B-5n5nB:
58.1		 5m54B-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M54_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
ASP B  26
HIS B 229
ALA B 233
SER B 236
PHE B 272
THR B 276
GLN B 281
 None
 0.93A 5m54B-5n5nB:
58.1		 5m54B-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M54_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
GLU B  27
ALA B 233
PHE B 272
THR B 276
GLN B 281
LEU B 371
 None
 1.04A 5m54B-5n5nB:
58.1		 5m54B-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M54_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
GLU B  27
HIS B 229
ALA B 233
PHE B 272
THR B 276
GLN B 281
 None
 0.89A 5m54B-5n5nB:
58.1		 5m54B-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M54_E_TA1E502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		9 / 12 VAL B  23
ASP B  26
ALA B 233
SER B 236
PHE B 272
THR B 276
GLN B 281
GLY B 370
LEU B 371
 None
 1.00A 5m54E-5n5nB:
58.0		 5m54E-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M54_E_TA1E502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		9 / 12 VAL B  23
ASP B  26
HIS B 229
ALA B 233
SER B 236
PHE B 272
THR B 276
GLN B 281
GLY B 370
 None
 0.95A 5m54E-5n5nB:
58.0		 5m54E-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M5C_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
ASP B  26
HIS B 229
LEU B 230
ALA B 233
THR B 276
GLN B 281
GLY B 370
 None
 1.08A 5m5cB-5n5nB:
58.7		 5m5cB-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M5C_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
ASP B  26
HIS B 229
SER B 236
THR B 276
GLN B 281
GLY B 370
 None
 0.94A 5m5cB-5n5nB:
58.7		 5m5cB-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M5C_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
ASP B  26
LEU B 230
ALA B 233
THR B 276
GLN B 281
GLY B 370
LEU B 371
 None
 1.07A 5m5cB-5n5nB:
58.7		 5m5cB-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M5C_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
ASP B  26
SER B 236
THR B 276
GLN B 281
GLY B 370
LEU B 371
 None
 1.02A 5m5cB-5n5nB:
58.7		 5m5cB-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M5C_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
GLU B  27
HIS B 229
LEU B 230
ALA B 233
THR B 276
GLN B 281
 None
 1.10A 5m5cB-5n5nB:
58.7		 5m5cB-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M5C_B_TA1B502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
GLU B  27
LEU B 230
ALA B 233
THR B 276
GLN B 281
LEU B 371
 None
 1.15A 5m5cB-5n5nB:
58.7		 5m5cB-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M5C_E_TA1E502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
HIS B 229
LEU B 230
ALA B 233
THR B 276
GLY B 370
 None
 1.06A 5m5cE-5n5nB:
58.6		 5m5cE-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M5C_E_TA1E502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 10 VAL B  23
ASP B  26
HIS B 229
SER B 236
THR B 276
GLY B 370
 None
 0.95A 5m5cE-5n5nB:
58.6		 5m5cE-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M5C_E_TA1E502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 10 VAL B  23
ASP B  26
LEU B 230
ALA B 233
THR B 276
GLY B 370
LEU B 371
 None
 1.04A 5m5cE-5n5nB:
58.6		 5m5cE-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M5C_E_TA1E502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 10 VAL B  23
ASP B  26
SER B 236
THR B 276
GLY B 370
LEU B 371
 None
 1.04A 5m5cE-5n5nB:
58.6		 5m5cE-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M5C_E_TA1E502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 10 VAL B  23
GLU B  27
HIS B 229
LEU B 230
ALA B 233
THR B 276
 None
 0.99A 5m5cE-5n5nB:
58.6		 5m5cE-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5M5C_E_TA1E502_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 10 VAL B  23
GLU B  27
LEU B 230
ALA B 233
THR B 276
LEU B 371
 None
 1.11A 5m5cE-5n5nB:
58.6		 5m5cE-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIO_B_LOCB502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 ALA B 250
ASN B 258
MET B 259
THR B 314
ILE B 378
 None
 0.82A 5mioB-5n5nB:
55.3		 5mioB-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIO_B_LOCB502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 LEU B 255
ASN B 258
MET B 259
THR B 314
ILE B 378
 None
 0.90A 5mioB-5n5nB:
55.3		 5mioB-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MIO_B_LOCB502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 LEU B 255
MET B 259
THR B 314
ALA B 316
ILE B 378
 None
 1.01A 5mioB-5n5nB:
55.3		 5mioB-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MM4_B_TA1B501_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 10 VAL B  23
GLU B  27
ALA B 233
PHE B 272
PRO B 360
LEU B 371
 None
 0.83A 5mm4B-5n5nB:
57.8		 5mm4B-5n5nB:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MM4_B_TA1B501_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 10 VAL B  23
GLU B  27
ALA B 233
PHE B 272
THR B 276
LEU B 371
 None
 1.08A 5mm4B-5n5nB:
57.8		 5mm4B-5n5nB:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MM4_B_TA1B501_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 10 VAL B  23
GLU B  27
HIS B 229
ALA B 233
PHE B 272
PRO B 360
 None
 0.75A 5mm4B-5n5nB:
57.8		 5mm4B-5n5nB:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MM4_B_TA1B501_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 10 VAL B  23
GLU B  27
HIS B 229
ALA B 233
PHE B 272
THR B 276
 None
 0.95A 5mm4B-5n5nB:
57.8		 5mm4B-5n5nB:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MM4_B_TA1B501_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 10 VAL B  23
GLU B  27
LEU B 219
ALA B 233
PRO B 360
LEU B 371
 None
 0.93A 5mm4B-5n5nB:
57.8		 5mm4B-5n5nB:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MM4_B_TA1B501_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 10 VAL B  23
GLU B  27
LEU B 219
HIS B 229
ALA B 233
PRO B 360
 None
 0.90A 5mm4B-5n5nB:
57.8		 5mm4B-5n5nB:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MM4_B_TA1B501_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 10 VAL B  23
HIS B 229
SER B 236
PHE B 272
PRO B 360
 None
 0.84A 5mm4B-5n5nB:
57.8		 5mm4B-5n5nB:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MM4_B_TA1B501_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 10 VAL B  23
HIS B 229
SER B 236
PHE B 272
THR B 276
 None
 1.01A 5mm4B-5n5nB:
57.8		 5mm4B-5n5nB:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MM4_B_TA1B501_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 10 VAL B  23
SER B 236
PHE B 272
PRO B 360
LEU B 371
 None
 0.88A 5mm4B-5n5nB:
57.8		 5mm4B-5n5nB:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5MM4_B_TA1B501_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 10 VAL B  23
SER B 236
PHE B 272
THR B 276
LEU B 371
 None
 1.11A 5mm4B-5n5nB:
57.8		 5mm4B-5n5nB:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ND2_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
ASP B  26
GLU B  27
HIS B 229
SER B 236
PHE B 272
ARG B 320
 None
 1.22A 5nd2B-5n5nB:
56.0		 5nd2B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ND2_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
HIS B 229
ALA B 233
PHE B 272
ARG B 320
 None
 1.19A 5nd2B-5n5nB:
56.0		 5nd2B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ND2_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
GLU B  27
HIS B 229
SER B 236
PHE B 272
ARG B 320
PRO B 360
LEU B 371
 None
 0.82A 5nd2B-5n5nB:
56.0		 5nd2B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ND2_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		9 / 12 VAL B  23
GLU B  27
LEU B 217
HIS B 229
ALA B 233
PHE B 272
ARG B 320
PRO B 360
LEU B 371
 None
 0.89A 5nd2B-5n5nB:
56.0		 5nd2B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ND3_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
HIS B 229
LEU B 230
THR B 276
ARG B 320
 None
 1.25A 5nd3B-5n5nB:
55.8		 5nd3B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ND3_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
HIS B 229
SER B 236
THR B 276
ARG B 320
 None
 1.23A 5nd3B-5n5nB:
55.8		 5nd3B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ND3_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		9 / 12 VAL B  23
GLU B  27
LEU B 217
HIS B 229
ALA B 233
SER B 236
THR B 276
ARG B 320
PRO B 360
 None
 1.04A 5nd3B-5n5nB:
55.8		 5nd3B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ND3_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		9 / 12 VAL B  23
GLU B  27
LEU B 217
HIS B 229
LEU B 230
ALA B 233
THR B 276
ARG B 320
PRO B 360
 None
 1.05A 5nd3B-5n5nB:
55.8		 5nd3B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ND4_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
ALA B 233
SER B 236
PHE B 272
PRO B 360
LEU B 371
 None
 0.91A 5nd4B-5n5nB:
56.3		 5nd4B-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ND4_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
GLU B  27
ALA B 233
PHE B 272
ARG B 320
PRO B 360
LEU B 371
 None
 1.04A 5nd4B-5n5nB:
56.3		 5nd4B-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ND4_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
GLU B  27
HIS B 229
ALA B 233
PHE B 272
ARG B 320
PRO B 360
 None
 0.96A 5nd4B-5n5nB:
56.3		 5nd4B-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ND4_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 VAL B  23
HIS B 229
ALA B 233
SER B 236
PHE B 272
PRO B 360
 None
 0.80A 5nd4B-5n5nB:
56.3		 5nd4B-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ND4_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
HIS B 229
LEU B 230
ALA B 233
PHE B 272
ARG B 320
PRO B 360
 None
 0.85A 5nd4B-5n5nB:
56.3		 5nd4B-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ND4_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
LEU B 230
ALA B 233
PHE B 272
ARG B 320
PRO B 360
LEU B 371
 None
 0.98A 5nd4B-5n5nB:
56.3		 5nd4B-5n5nB:
97.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ND7_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		9 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
HIS B 229
ALA B 233
SER B 236
PHE B 272
LEU B 371
 None
 1.22A 5nd7B-5n5nB:
55.8		 5nd7B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5ND7_B_TA1B601_1
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		10 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
HIS B 229
LEU B 230
ALA B 233
PHE B 272
ARG B 320
LEU B 371
 None
 1.23A 5nd7B-5n5nB:
55.8		 5nd7B-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5NM5_B_LOCB502_2
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 LEU B 255
ASN B 258
MET B 259
THR B 314
ILE B 378
 None
 0.93A 5nm5B-5n5nB:
54.6		 5nm5B-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5NM5_B_LOCB502_2
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 LEU B 255
MET B 259
THR B 314
ALA B 316
ILE B 378
 None
 1.05A 5nm5B-5n5nB:
54.6		 5nm5B-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5NM5_B_LOCB502_2
(TUBULIN BETA-2B
CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 MET B 259
THR B 314
ALA B 316
ALA B 354
ILE B 378
 None
 0.76A 5nm5B-5n5nB:
54.6		 5nm5B-5n5nB:
97.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5OGC_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 VAL B  23
ASP B  26
GLU B  27
HIS B 229
SER B 236
 None
 1.11A 5ogcB-5n5nB:
55.1		 5ogcB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5OGC_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
HIS B 229
 None
 1.05A 5ogcB-5n5nB:
55.1		 5ogcB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5OGC_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 VAL B  23
ASP B  26
GLU B  27
SER B 236
LEU B 371
 None
 1.23A 5ogcB-5n5nB:
55.1		 5ogcB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5OGC_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
GLU B  27
HIS B 229
SER B 236
THR B 276
PRO B 360
GLY B 370
 None
 0.77A 5ogcB-5n5nB:
55.1		 5ogcB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5OGC_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
GLU B  27
LEU B 217
HIS B 229
THR B 276
PRO B 360
GLY B 370
 None
 0.70A 5ogcB-5n5nB:
55.1		 5ogcB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5OGC_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
GLU B  27
LEU B 217
THR B 276
PRO B 360
GLY B 370
LEU B 371
 None
 0.89A 5ogcB-5n5nB:
55.1		 5ogcB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5OGC_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
GLU B  27
SER B 236
THR B 276
PRO B 360
GLY B 370
LEU B 371
 None
 0.91A 5ogcB-5n5nB:
55.1		 5ogcB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5OGC_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
HIS B 229
SER B 236
PHE B 272
THR B 276
PRO B 360
GLY B 370
 None
 0.95A 5ogcB-5n5nB:
55.1		 5ogcB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5OGC_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
LEU B 217
HIS B 229
PHE B 272
THR B 276
PRO B 360
GLY B 370
 None
 0.83A 5ogcB-5n5nB:
55.1		 5ogcB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5OGC_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
LEU B 217
PHE B 272
THR B 276
PRO B 360
GLY B 370
LEU B 371
 None
 0.96A 5ogcB-5n5nB:
55.1		 5ogcB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5OGC_B_TA1B601_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		7 / 12 VAL B  23
SER B 236
PHE B 272
THR B 276
PRO B 360
GLY B 370
LEU B 371
 None
 1.04A 5ogcB-5n5nB:
55.1		 5ogcB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5SYE_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		11 / 12 GLU B  22
VAL B  23
ASP B  26
LEU B 217
ASP B 226
HIS B 229
ALA B 233
SER B 236
ARG B 320
PRO B 360
GLY B 370
 None
 0.71A 5syeB-5n5nB:
60.1		 5syeB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5SYE_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		6 / 12 GLU B  22
VAL B  23
ASP B  26
LEU B 275
HIS B 229
GLY B 370
 None
 1.23A 5syeB-5n5nB:
60.1		 5syeB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5SYE_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		10 / 12 GLU B  22
VAL B  23
LEU B 217
HIS B 229
ALA B 233
SER B 236
GLN B 281
ARG B 320
PRO B 360
GLY B 370
 None
 0.97A 5syeB-5n5nB:
60.1		 5syeB-5n5nB:
97.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5SYF_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		10 / 12 VAL B  23
ASP B  26
LEU B 217
ASP B 226
HIS B 229
ALA B 233
SER B 236
GLN B 281
PRO B 360
LEU B 371
 None
 1.34A 5syfB-5n5nB:
61.1		 5syfB-5n5nB:
97.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5TL8_A_X2NA502_2
(PROTEIN CYP51)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		4 / 6 PRO B 360
PRO B 274
LEU B 291
LEU B 275
 None
 1.04A 5tl8A-5n5nB:
undetectable		 5tl8A-5n5nB:
21.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5U6M_B_SALB503_1
(UDP-GLYCOSYLTRANSFER
ASE 74F2)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		4 / 7 HIS B   6
PHE B  20
GLN B 136
THR B 239
 None
 1.42A 5u6mB-5n5nB:
3.3		 5u6mB-5n5nB:
22.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5U6N_A_SALA505_1
(UDP-GLYCOSYLTRANSFER
ASE 74F2)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		4 / 8 HIS B   6
PHE B  20
GLN B 136
THR B 239
 None
 1.40A 5u6nA-5n5nB:
2.7		 5u6nA-5n5nB:
22.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5U6N_B_SALB504_1
(UDP-GLYCOSYLTRANSFER
ASE 74F2)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		4 / 6 HIS B   6
PHE B  20
GLN B 136
THR B 239
 None
 1.45A 5u6nB-5n5nB:
4.3		 5u6nB-5n5nB:
22.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5XIO_B_HFGB802_0
(PROLINE-TRNA
SYNTHETASE CLASS II
AARS (YBAK RNA
BINDING DOMAIN PLUS
TRNA SYNTHETASE))		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 12 VAL B 318
THR B 239
PHE B  20
THR B 138
HIS B   6
 None
 1.49A 5xioB-5n5nB:
undetectable		 5xioB-5n5nB:
21.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6B0I_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		9 / 12 VAL B  23
ASP B  26
LEU B 217
ASP B 226
HIS B 229
LEU B 230
ALA B 233
SER B 236
LEU B 371
 None
 0.97A 6b0iB-5n5nB:
59.9		 6b0iB-5n5nB:
95.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6B0I_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		10 / 12 VAL B  23
LEU B 217
ASP B 226
HIS B 229
LEU B 230
ALA B 233
SER B 236
PRO B 360
GLY B 370
LEU B 371
 None
 0.73A 6b0iB-5n5nB:
59.9		 6b0iB-5n5nB:
95.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6B0L_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
ASP B  26
LEU B 217
ASP B 226
HIS B 229
LEU B 230
SER B 236
PRO B 360
 None
 1.07A 6b0lB-5n5nB:
59.5		 6b0lB-5n5nB:
95.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6B0L_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
ASP B  26
LEU B 217
ASP B 226
HIS B 229
LEU B 230
SER B 236
THR B 276
 None
 1.12A 6b0lB-5n5nB:
59.5		 6b0lB-5n5nB:
95.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6B0L_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
ASP B  26
LEU B 217
ASP B 226
LEU B 230
SER B 236
PRO B 360
LEU B 371
 None
 1.09A 6b0lB-5n5nB:
59.5		 6b0lB-5n5nB:
95.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6B0L_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
ASP B  26
LEU B 217
ASP B 226
LEU B 230
SER B 236
THR B 276
LEU B 371
 None
 1.19A 6b0lB-5n5nB:
59.5		 6b0lB-5n5nB:
95.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6B0L_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
LEU B 217
ASP B 226
HIS B 229
LEU B 230
SER B 236
PRO B 360
GLY B 370
 None
 0.82A 6b0lB-5n5nB:
59.5		 6b0lB-5n5nB:
95.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6B0L_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
LEU B 217
ASP B 226
HIS B 229
LEU B 230
SER B 236
THR B 276
GLY B 370
 None
 0.94A 6b0lB-5n5nB:
59.5		 6b0lB-5n5nB:
95.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6B0L_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
LEU B 217
ASP B 226
LEU B 230
SER B 236
PRO B 360
GLY B 370
LEU B 371
 None
 0.92A 6b0lB-5n5nB:
59.5		 6b0lB-5n5nB:
95.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6B0L_B_TA1B502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		8 / 12 VAL B  23
LEU B 217
ASP B 226
LEU B 230
SER B 236
THR B 276
GLY B 370
LEU B 371
 None
 1.05A 6b0lB-5n5nB:
59.5		 6b0lB-5n5nB:
95.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6EU9_B_REAB601_1
(RETINOIC ACID
RECEPTOR)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		5 / 10 VAL B 118
LEU B 119
GLY B 150
GLY B  95
VAL B  93
 None
 0.99A 6eu9B-5n5nB:
undetectable		 6eu9B-5n5nB:
11.08
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EW0_B_TA1B501_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		9 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
HIS B 229
ALA B 233
SER B 236
GLN B 281
LEU B 371
 None
 0.84A 6ew0B-5n5nB:
62.1		 6ew0B-5n5nB:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EW0_B_TA1B501_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		10 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
LEU B 219
HIS B 229
ALA B 233
LEU B 275
GLN B 281
LEU B 371
 None
 0.88A 6ew0B-5n5nB:
62.1		 6ew0B-5n5nB:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EW0_B_TA1B501_2
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		4 / 5 LEU B 230
THR B 276
ARG B 320
PRO B 360
 None
 0.62A 6ew0B-5n5nB:
62.1		 6ew0B-5n5nB:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EW0_D_TA1D501_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		9 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
HIS B 229
ALA B 233
SER B 236
GLN B 281
LEU B 371
 None
 0.85A 6ew0D-5n5nB:
62.1		 6ew0D-5n5nB:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EW0_D_TA1D501_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		10 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
LEU B 219
HIS B 229
ALA B 233
LEU B 275
GLN B 281
LEU B 371
 None
 0.88A 6ew0D-5n5nB:
62.1		 6ew0D-5n5nB:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EW0_D_TA1D501_2
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		4 / 5 LEU B 230
THR B 276
ARG B 320
PRO B 360
 None
 0.62A 6ew0D-5n5nB:
62.1		 6ew0D-5n5nB:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EW0_F_TA1F502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		10 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
ASP B 226
HIS B 229
ALA B 233
LEU B 275
GLN B 281
LEU B 371
 None
 0.86A 6ew0F-5n5nB:
62.1		 6ew0F-5n5nB:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EW0_F_TA1F502_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		10 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
ASP B 226
HIS B 229
ALA B 233
SER B 236
GLN B 281
LEU B 371
 None
 0.88A 6ew0F-5n5nB:
62.1		 6ew0F-5n5nB:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EW0_F_TA1F502_2
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		4 / 5 LEU B 219
LEU B 230
THR B 276
PRO B 360
 None
 0.84A 6ew0F-5n5nB:
62.1		 6ew0F-5n5nB:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EW0_G_TA1G501_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		10 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
HIS B 229
ALA B 233
PHE B 272
LEU B 275
GLN B 281
LEU B 371
 None
 0.80A 6ew0G-5n5nB:
62.1		 6ew0G-5n5nB:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EW0_G_TA1G501_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		10 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
HIS B 229
ALA B 233
SER B 236
PHE B 272
GLN B 281
LEU B 371
 None
 0.83A 6ew0G-5n5nB:
62.1		 6ew0G-5n5nB:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EW0_H_TA1H501_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		9 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
HIS B 229
ALA B 233
SER B 236
GLN B 281
LEU B 371
 None
 0.84A 6ew0H-5n5nB:
62.1		 6ew0H-5n5nB:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EW0_H_TA1H501_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		10 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
LEU B 219
HIS B 229
ALA B 233
LEU B 275
GLN B 281
LEU B 371
 None
 0.88A 6ew0H-5n5nB:
62.1		 6ew0H-5n5nB:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EW0_H_TA1H501_2
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		4 / 5 LEU B 230
THR B 276
ARG B 320
PRO B 360
 None
 0.62A 6ew0H-5n5nB:
undetectable		 6ew0H-5n5nB:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EW0_I_TA1I501_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		9 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
HIS B 229
ALA B 233
SER B 236
GLN B 281
LEU B 371
 None
 0.84A 6ew0I-5n5nB:
62.1		 6ew0I-5n5nB:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EW0_I_TA1I501_1
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		10 / 12 VAL B  23
ASP B  26
GLU B  27
LEU B 217
LEU B 219
HIS B 229
ALA B 233
LEU B 275
GLN B 281
LEU B 371
 None
 0.87A 6ew0I-5n5nB:
62.1		 6ew0I-5n5nB:
93.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6EW0_I_TA1I501_2
(TUBULIN BETA CHAIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		4 / 5 LEU B 230
THR B 276
ARG B 320
PRO B 360
 None
 0.62A 6ew0I-5n5nB:
undetectable		 6ew0I-5n5nB:
93.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6FGD_A_ACTA806_0
(GEPHYRIN)		 5n5n TUBULIN BETA CHAIN
(Homo
sapiens) 		4 / 4 MET B 149
GLY B 148
HIS B 107
GLY B 111
 None
 1.18A 6fgdA-5n5nB:
undetectable		 6fgdA-5n5nB:
22.38